Skip to main content

Advertisement

SpringerLink
Log in

Extension of the Lifespan of a Mouse Model of Rett Syndrome by Intracerebroventricular Delivery of MECP2

  • Letter to the Editor
  • Published:
Neuroscience Bulletin Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Qiu ZL, Sylwestrak EL, Lieberman DN, Zhang Y, Liu XY, Ghosh A. The Rett syndrome protein MeCP2 regulates synaptic scaling. J Neurosci 2012, 32: 989–994.

    Article  CAS  Google Scholar 

  2. Kirby RS, Lane JB, Childers J, Skinner SA, Annese F, Barrish JO. Longevity in Rett syndrome: Analysis of the North American Database. J Pediatr 2010, 156: 135-138.e1.

    Article  Google Scholar 

  3. Amir RE, van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999, 23: 185–188.

    Article  CAS  Google Scholar 

  4. Zhang ZC, Han JH. The first national prevalence of autism spectrum disorder in China. Neurosci Bull 2020, 36: 959–960.

    Article  CAS  Google Scholar 

  5. Lyst MJ, Bird A. Rett syndrome: A complex disorder with simple roots. Nat Rev Genet 2015, 16: 261–275.

    Article  CAS  Google Scholar 

  6. Zhou ZL, Hong EJ, Cohen S, Zhao WN, Ho HYH, Schmidt L, et al. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 2006, 52: 255–269.

    Article  CAS  Google Scholar 

  7. Foust KD, Nurre E, Montgomery CL, Hernandez A, Chan CM, Kaspar BK. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol 2009, 27: 59–65.

    Article  CAS  Google Scholar 

  8. Gadalla KKE, Bailey MES, Spike RC, Ross PD, Woodard KT, Kalburgi SN, et al. Improved survival and reduced phenotypic severity following AAV9/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice. Mol Ther 2013, 21: 18–30.

    Article  CAS  Google Scholar 

  9. Sinnett SE, Hector RD, Gadalla KKE, Heindel C, Chen D, Zaric V, et al. Improved MECP2 gene therapy extends the survival of MeCP2-null mice without apparent toxicity after intracisternal delivery. Mol Ther Methods Clin Dev 2017, 5: 106–115.

    Article  CAS  Google Scholar 

  10. Zuo EW, Cai YJ, Li K, Wei Y, Wang BG, Sun YD, et al. One-step generation of complete gene knockout mice and monkeys by CRISPR/Cas9-mediated gene editing with multiple sgRNAs. Cell Res 2017, 27: 933–945.

    Article  CAS  Google Scholar 

  11. Garg SK, Lioy DT, Cheval H, McGann JC, Bissonnette JM, Murtha MJ, et al. Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome. J Neurosci 2013, 33: 13612–13620.

    Article  CAS  Google Scholar 

  12. Tillotson R, Selfridge J, Koerner MV, Gadalla KKE, Guy J, de Sousa D, et al. Radically truncated MeCP2 rescues Rett syndrome-like neurological defects. Nature 2017, 550: 398–401.

    Article  CAS  Google Scholar 

  13. Pohl AL, Crockford SK, Blakemore M, Allison C, Baron-Cohen S. A comparative study of autistic and non-autistic women’s experience of motherhood. Mol Autism 2020, 11: 3.

    Article  CAS  Google Scholar 

  14. Gray SJ, Foti SB, Schwartz JW, Bachaboina L, Taylor-Blake B, Coleman J, et al. Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors. Hum Gene Ther 2011, 22: 1143–1153.

    Article  CAS  Google Scholar 

  15. Gray SJ, Nagabhushan Kalburgi S, McCown TJ, Jude Samulski R. Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates. Gene Ther 2013, 20: 450–459.

    Article  CAS  Google Scholar 

  16. Lioy DT, Garg SK, Monaghan CE, Raber J, Foust KD, Kaspar BK, et al. A role for glia in the progression of Rett’s syndrome. Nature 2011, 475: 497–500.

    Article  CAS  Google Scholar 

  17. Luikenhuis S, Giacometti E, Beard CF, Jaenisch R. Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proc Natl Acad Sci U S A 2004, 101: 6033–6038.

    Article  CAS  Google Scholar 

  18. Ballas N, Lioy DT, Grunseich C, Mandel G. Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat Neurosci 2009, 12: 311–317.

    Article  CAS  Google Scholar 

  19. Chen RZ, Akbarian S, Tudor M, Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 2001, 27: 327–331.

    Article  CAS  Google Scholar 

  20. Guy J, Gan J, Selfridge J, Cobb S, Bird A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 2007, 315: 1143–1147.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the Youth Innovation Promotion Association Chinese Academy of Sciences (2022269), the Youth Science Fund of State Key Laboratory of Neuroscience(SKLN-2022B006), the National Natural Science Foundation of China (82001211, 81941015, and 82021001), the CPSF-CAS Joint Foundation for Excellent Postdoctoral Fellows (2017LH036), the China Postdoctoral Science Foundation (2017M620173), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDBS01060200), the Program of Shanghai Academic Research Leader, the Open Large Infrastructure Research of Chinese Academy of Sciences, the Shanghai Municipal Science and Technology Major Project (2018SHZDZX05), and the Guangdong Key Scientific and Technological Project (2018B030335001).

Author information

Authors and Affiliations

  1. Center for Excellence in Brain Science and Intelligence Technology, Institute of Neuroscience, State Key Laboratory of Neuroscience, CAS Key Laboratory of Primate Neurobiology, Chinese Academy of Sciences, Shanghai, 200031, China

    Kan Yang, Yiting Yuan, Yuefang Zhang, Shifang Shan & Zilong Qiu

  2. Belief BioMed (Shanghai), Co., Ltd., Shanghai, 200032, China

    Cheng Cheng

  3. National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, China

    Zilong Qiu

Authors
  1. Kan Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cheng Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yiting Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuefang Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shifang Shan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zilong Qiu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Kan Yang or Zilong Qiu.

Ethics declarations

Conflict of interest

These authors declare no competing interests.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 307 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, K., Cheng, C., Yuan, Y. et al. Extension of the Lifespan of a Mouse Model of Rett Syndrome by Intracerebroventricular Delivery of MECP2. Neurosci. Bull. 39, 297–302 (2023). https://doi.org/10.1007/s12264-022-00974-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12264-022-00974-y

Search

Navigation